← Eichor
Condition: Mouth Ulcer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mouth Ulcer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT05335434Effects of Photobiomodulation (PBM) on Pain After Presentation of Aphthous Ulcers in Pediatric Dental Patients
Phase 4 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06819033A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
Phase 3 · 7 location(s) · Amgen · NCT05767047Combination of Diet and Oral Budesonide for Ulcerative Colitis
NA · 6 location(s) · Wolfson Medical Center · NCT05791487Salivary E-cadherin, Calprotectin, and Matrix Metalloproteinase-9 Levels in Recurrent Aphthous Stomatitis
Phase N/A · 1 location(s) · Selin Yeşiltepe · NCT07141758High Dose Oral Omeprazole in High Risk UGIB
NA · 2 location(s) · King Chulalongkorn Memorial Hospital · NCT04394663Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07683104The Preventive and Therapeutic Effects of Spirulina Preparations on Ulcers of Oral Mucosa
NA · 1 location(s) · The Fourth Affiliated Hospital of Zhejiang University School · NCT07723612Lenalidomide in the Treatment of Mucosal Behçet's Syndrome
NA · 1 location(s) · Peking Union Medical College Hospital · NCT05449548A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
Phase 1/Phase 2 · 1 location(s) · Mage Biologics · NCT07374471Observational Study of OROSEDAL in Sore Throat and Minor Oral Lesions
Phase N/A · 1 location(s) · Laboratoires Elerte · NCT07620353Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients
NA · 1 location(s) · Mucosa Innovations, S.L. · NCT05635929Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg
NA · 2 location(s) · Valenta Pharm JSC · NCT06098742Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis
NA · 1 location(s) · Showa Inan General Hospital · NCT07243639Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.
Phase 2 · 1 location(s) · Mansoura University · NCT06354712Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
Phase 2/Phase 3 · 1 location(s) · West China Hospital · NCT06798363Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers
Phase 2/Phase 3 · 1 location(s) · British University In Egypt · NCT06910579Using a Steroid Mouthwash to Prevent Mouth Sores During Chemotherapy
Phase 4 · 1 location(s) · Woman's · NCT07287826Coconut Oil to Prevent Mouth Sores in Pediatric Patients Receiving High Dose Chemotherapy
Phase 2 · 1 location(s) · Wake Forest University Health Sciences · NCT05441813Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NI
Phase 1 · 52 location(s) · National Cancer Institute (NCI) · NCT03816345Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately A
Phase 2/Phase 3 · 26 location(s) · University Hospital Schleswig-Holstein · NCT06488625Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
Phase 2 · 28 location(s) · InSilico Medicine Hong Kong Limited · NCT07265570PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
Phase 4 · 8 location(s) · Chinese University of Hong Kong · NCT05582174Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
Phase 3 · 27 location(s) · Amgen · NCT04528082Oral Vitamin D3 Effect on Inflammatory Biomarkers in Ulcerative Colitis Patients
NA · 1 location(s) · University of Veterinary and Animal Sciences, Lahore - Pakis · NCT07269223A Study to Describe the Effect of Photobiomodulation (Low Level Laser Therapy) in Reducing the Severity and Incidence of
NA · 1 location(s) · Peter MacCallum Cancer Centre, Australia · NCT07387978A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Phase 2 · 16 location(s) · Takeda · NCT06764615PROSENIOR. Prevention of Pressure Ulcers, Malnutrition, Poor Oral Health and Falls Among Older Persons Receiving Municip
NA · 1 location(s) · Malmö University · NCT05308862Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of
Phase 2 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT04373473A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Coliti
Phase 2/Phase 3 · 90 location(s) · Bristol-Myers Squibb · NCT05076175
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.